Deakin University
Browse

File(s) under permanent embargo

Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

Version 2 2024-08-15, 23:38
Version 1 2023-04-03, 05:47
journal contribution
posted on 2024-08-15, 23:38 authored by Navid Shomali, Behzad Baradaran, Amin Daei Sorkhabi, Aila Sarkesh, Mohammad Saeed Kahrizi, Foad Tosan, Ata Mahmoodpoor, Amirhossein Mardi, Hamed Mohammadi, Ali Hassanzadeh, Hossein Saeedi, Mehrzad Hajialilo, Maryam Hemmatzadeh, Faroogh Marofi, Siamak Sandoghchian Shotorbani
Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

History

Journal

Gene

Volume

844

Article number

146829

Pagination

1-9

Location

Amsterdam, The Netherlands

Publisher DOI

ISSN

0378-1119

eISSN

1879-0038

Language

en

Author URL

Publication classification

C1.1 Refereed article in a scholarly journal

Publisher

Elsevier

Usage metrics

    Research Publications

    Categories

    Keywords

    ankylosing spondylitisSurvivinCaspase 9miRNAAutoreactive T cellsApoptosisAnkylosing spondylitisCell Line, TumorHumansInhibitor of Apoptosis ProteinsLeukocytes, MononuclearMicroRNAsSpondylitis, AnkylosingT-Lymphocytes

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC